Failure of Guanidine and 2-( -Hydroxybenzyl)benzimidazole to Inhibit Replication of Hepatitis A Virus In vitro
- 1 July 1982
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 61 (1) , 111-114
- https://doi.org/10.1099/0022-1317-61-1-111
Abstract
Replication of hepatitis A virus (HAV) in the human hepatoma-derived PLC/PRF/5 cell line was neither inhibited in the presence of various concentrations of guanidine or D-2-(.alpha.-hydroxybenzyl)benzimidazole (D-HBB), nor were the 2 chemicals effective in combination. Under identical conditions, replication of poliovirus type 1 was inhibited. Tracer experiments with radiolabeled guanidine and D-HBB also furnished no evidence that the 2 antiviral substances were metabolized gradually to inactive derivatives in PLC/PRF/5 cells. Resistance to the action of guanidine and D-HBB appears to be an inherent characteristic of HAV. However, the insensitivity of HAV to these drugs does not exclude the virus from the family of picornaviruses.Keywords
This publication has 5 references indexed in Scilit:
- The Physicochemical Properties of Infectious Hepatitis A VirionsJournal of General Virology, 1981
- Evidence that the genome of hepatitis A virus consists of single-stranded RNAJournal of Virology, 1980
- Iodination of hepatitis A virus reveals a fourth structural polypeptideJournal of Virology, 1980
- On the mechanism of selective inhibition of enterovirus multiplication by 2-(α-hydroxybenzyl)-benzimidazoleVirology, 1962
- SPECTRUM AND CHARACTERISTICS OF THE VIRUS INHIBITORY ACTION OF 2-(α-HYDROXYBENZYL)-BENZIMIDAZOLEThe Journal of Experimental Medicine, 1961